Peptide fact checks.

FDA approves a specific product for specific uses. The current Wegovy label lists different forms, groups of people, uses, and limits.

What this answer is based on

Official record or product label
This answer uses an official regulator record or a specific product label.

Applies to

The exact semaglutide products, forms, people, and uses named in current FDA labels.

FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing.

What this answer is based on

Official record or product label
This answer uses an official regulator record or a specific product label.

Applies to

Compounded or otherwise unapproved semaglutide products compared with FDA-approved products.

A study supports only the people, product form, dose, length, approved use, and result that it tested.

What this answer is based on

Health results from a study with randomly assigned groups
This answer uses a study that assigned people to groups by chance and measured a health outcome.

Applies to

The people, product forms, measured results, and study lengths described in the cited product record.

Several insulin products have FDA approval. Long-term studies in people support closely monitored insulin plans for specific groups with diabetes. The exact product and care setting still matter.

What this answer is based on

Health results from a study with randomly assigned groups
This answer uses a study that assigned people to groups by chance and measured a health outcome.

Applies to

FDA-approved insulin products and closely monitored treatment plans for specific groups with diabetes.

Insulin products can differ in how fast they work and how much medicine they contain. They can also differ in how they enter the body and what their FDA labels allow. Some biosimilars can be substituted under state law. This does not make every insulin product freely exchangeable.

What this answer is based on

Official record or product label
This answer uses an official regulator record or a specific product label.

Applies to

The exact insulin products, amounts of medicine, ways to give them, and labels reviewed.

The DCCT found fewer long-term complications with an intensive plan. It also found about two to three times as many severe low-blood-sugar events. The right treatment level differs by person and needs medical monitoring.

What this answer is based on

Health results from a study with randomly assigned groups
This answer uses a study that assigned people to groups by chance and measured a health outcome.

Applies to

The specific intensive plan and people with type 1 diabetes studied in the DCCT.

Posted product labels, an August 2026 FDA approval letter, and large randomized trials support specific blood-sugar, weight, and cardiovascular findings in defined populations. The cardiovascular risk-reduction use belongs to Mounjaro.

What this answer is based on

Health results from a study with randomly assigned groups
This answer uses a study that assigned people to groups by chance and measured a health outcome.

Applies to

The labeled and trial populations, outcomes, comparators, and durations for Mounjaro and Zepbound. Mounjaro's heart-risk use was approved August 27, 2026.

Trials estimate effects for studied populations and durations. They do not establish an identical individual response or a universal treatment duration.

What this answer is based on

Health results from a study with randomly assigned groups
This answer uses a study that assigned people to groups by chance and measured a health outcome.

Applies to

The defined populations and follow-up durations in SURMOUNT-1 and SURPASS-2.

FDA does not review compounded drugs for safety, effectiveness, or quality before marketing, so evidence for an approved product cannot simply be transferred.

What this answer is based on

Official record or product label
This answer uses an official regulator record or a specific product label.

Applies to

Compounded or otherwise unapproved tirzepatide compared with approved Mounjaro or Zepbound.

Cell and rat tendon studies report positive healing signals. The scope matters: these results support biological plausibility, not a proven human treatment.

What this answer is based on

Cell, animal, or other lab research
This answer uses research in cells, animals, or other settings outside patient care. It does not show a benefit in people.

Applies to

Cell and animal tendon models only; not clinical healing outcomes in people.

Early human work is too small and limited to establish efficacy. Reliable, replicated human outcome evidence is still needed.

What this answer is based on

No reliable studies showing this health result in people
No reliable study in people shows the health outcome in this statement.

Applies to

Human tendon and muscle-healing claims; existing pilots and a trial registration do not establish benefit.

The 2026 WADA Prohibited List places BPC-157 in S0 non-approved substances, which is prohibited at all times for covered athletes. Whether it is a steroid is irrelevant to that status.

What this answer is based on

Official record or product label
This answer uses an official regulator record or a specific product label.

Applies to

Athletes subject to the current WADA Code and their applicable governing-body rules.

Studies in people found that both hormones stayed higher for a time. This is a change in body measurements, not proof of a health benefit.

What this answer is based on

Studies of body changes in people
This answer uses a study of how the substance enters or changes the body in people. This alone does not show a health benefit.

Applies to

Short-term changes in GH and IGF-1 measured in the healthy adults studied.

The cited studies did not test lasting changes in body fat, muscle, or what people could do physically.

What this answer is based on

No reliable studies showing this health result in people
No reliable study in people shows the health outcome in this statement.

Applies to

Lasting changes in body fat, muscle, or what people could do physically. The cited hormone studies did not test these outcomes.

Research papers and sellers may use the name for different forms, including different salts, changed versions, or mixtures with other ingredients.

What this answer is based on

Official record or product label
This answer uses an official regulator record or a specific product label.

Applies to

Products labeled CJC-1295 that differ in form, salt, chemical changes, added ingredients, or quality controls.

A human dose-escalation study measured an episode of GH release. That is a pharmacodynamic effect.

What this answer is based on

Studies of body changes in people
This answer uses a study of how the substance enters or changes the body in people. This alone does not show a health benefit.

Applies to

Short-term GH pharmacodynamics in the healthy volunteers and route studied.

A biomarker response is not a clinical outcome, and the identified studies did not establish those benefits.

What this answer is based on

No reliable studies showing this health result in people
No reliable study in people shows the health outcome in this statement.

Applies to

Recovery and body-composition outcomes not established by GH pharmacology or the postoperative-ileus trial.

The randomized trial reported no significant difference from placebo on its key and secondary efficacy analyses.

What this answer is based on

Health results from a study with randomly assigned groups
This answer uses a study that assigned people to groups by chance and measured a health outcome.

Applies to

The postoperative-ileus population, intervention, and efficacy endpoints in the phase 2 trial.

Yes, for defined products, populations, indications, comparators, endpoints, and durations studied in major trials and reviewed labels.

What this answer is based on

Health results from a study with randomly assigned groups
This answer uses a study that assigned people to groups by chance and measured a health outcome.

Applies to

Approved liraglutide products used in the populations and indications studied.

Approved-product evidence includes product quality and labeling that cannot be assumed for every compounded or unapproved item.

What this answer is based on

Official record or product label
This answer uses an official regulator record or a specific product label.

Applies to

Product identity, formulation, quality, and labeling all matter.